3136 results for «2950»
3136 results
Novel tools and strategies in chronic heart failure
21 May 2025 – From EuroPCR 2025
Discover novel tools and therapeutic strategies in chronic heart failure management. This session presents early clinical experiences with innovative devices such as a chronically-adjustable pressure sensing interatrial shunt, synchronized diaphragmatic stimulation, high-flow pLVADs for cardiogenic shock, and renal artery denervation. Additionally, it reviews the impact of...
Challenging scenarios in the pulmonary system - Part 1
21 May 2025 – From EuroPCR 2025
This session presents challenging pulmonary system cases including high-risk and intermediate-high risk pulmonary embolism, complex congenital heart disease, and rare cardiac conditions. Understand critical management strategies for these uncommon but urgent scenarios.
How imaging can improve efficiency in CTO PCI
21 May 2025 – From EuroPCR 2025
Discover how advanced imaging techniques improve efficiency in CTO PCI procedures. This session features IVUS-guided antegrade dissection, angio-CT guided retrograde recanalisation, and complex cases involving anomalous anatomy and multiple bifurcations.
Managing ischaemic and bleeding risk of NSTEMI patients
22 May 2025 – From EuroPCR 2025
Gain valuable insights into managing ischemic and bleeding risks in NSTEMI patients. This session reviews optimal timing for invasive strategies, variability in care processes, radial access approaches, and innovative antithrombotic strategies such as aspirin omission and prasugrel monotherapy to minimize bleeding while optimizing outcomes.
Strategic decision in stent failure
20 May 2025 – From EuroPCR 2025
Explore strategic decision-making in cases of stent failure in this session presenting complex clinical scenarios. Through detailed case analyses, including challenging left main trifurcation lesions and NSTEMI in the presence of chronic total occlusions, discover treatment approaches and key learnings to optimize patient outcomes.
CTO PCI with Asian flavour
20 May 2025 – From EuroPCR 2025
Learn contemporary tips and tricks for chronic total occlusion (CTO) percutaneous coronary intervention (PCI) with an emphasis on specific algorithms to enhance procedural efficiency and safety. This session addresses overcoming obstacles in antegrade and retrograde approaches and managing potential complications through real-world case examples.
A mindset shift in the cathlab: leveraging contemporary technologies for planning and guiding PCI in complex patients
22 May 2025 – From EuroPCR 2025
This session examines evolving catheterisation lab workflows, highlighting how integrated imaging, physiology, and procedural strategies are reshaping PCI practices. Speakers emphasize the importance of advanced pre-procedural planning using modalities such as intravascular ultrasound (IVUS) to optimise stent deployment, and cardiac computed tomography angiography (CCTA) to improve diagnosis...
Troubleshooting in left main stenting: the role of imaging and physiology
20 May 2025 – From EuroPCR 2025
Expand your expertise on left main stenting by integrating intravascular imaging and physiology to improve outcomes. This session focuses on avoiding and managing stent deformation and optimal treatment of ostial left circumflex artery after crossover stenting, illustrated by clinical cases and expert commentary.
A simple low profile solution to the pulmonary embolism problem: EKOS
21 May 2025 – From EuroPCR 2025
Discover a streamlined approach to pulmonary embolism treatment in this EuroPCR 2025 session. Learn how ultrasound-assisted thrombolysis improves right ventricular function and pulmonary perfusion while enabling timely reperfusion with low-dose thrombolytic therapy delivered directly to the clot. Explore the latest data from the HI-PEITHO randomised trial...
Active posterior leaflet replacement - A novel transcatheter approach for the treatment of primary and secondary mitral regurgitation
21 May 2025 – From EuroPCR 2025
Find out more about an innovative transcatheter strategy for managing both primary and secondary mitral regurgitation in this EuroPCR 2025 session. Experts introduce the concept of active posterior leaflet replacement and present the Polares MRace device—a novel solution designed to address the limitations of current therapies....
My approach for a calcified bifurcation lesion
20 May 2025 – From EuroPCR 2025
This session provides a comprehensive approach to managing calcified bifurcation lesions. Learn how to interpret angiographic and intravascular imaging, plan interventions with appropriate devices for simplicity and safety, and evaluate final results to understand their clinical impact through real cases.
Advanced imaging in structural heart disease interventions
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session brings together expert insights on the evolving role of 3D intracardiac echocardiography (ICE) in procedures like LAA closure, Mitral TEER, and Tricuspid TEER—highlighting how this advanced modality is reshaping procedural guidance.
You'll also discover how AI-enabled device detection technology is being integrated into...
Advancing renal denervation in China: from guidelines to practice
20 May 2025 – From EuroPCR 2025
Discover how renal denervation (RDN) is rapidly evolving in China to meet the needs of patients with uncontrolled hypertension. This EuroPCR 2025 session highlights recent guideline endorsements and approvals, patient selection based on drug resistance and cardiovascular risk, and the critical role of diagnostic screening. Gain...
Mitral and tricuspid hotline: long-term outcomes
20 May 2025 – From EuroPCR 2025
Review long-term outcomes of transcatheter edge-to-edge repair (TEER) for mitral and tricuspid valve disease in this session. Highlights include pivotal trial results, mortality risk prediction tools, management of procedural failures, and real-world data, providing comprehensive insights into patient prognosis and therapeutic impact.
Advancing the standard of care in PCI with Bioadaptor: from simple to complex
21 May 2025 – From EuroPCR 2025
This session provides an in-depth overview of Bioadapter technology and its potential to overcome the limitations of current drug-eluting stents (DES) in percutaneous coronary intervention (PCI). Speakers present data from recent trials, including the Bioadapter RCT and the Infinity Sweetheart study, demonstrating a reduction in target lesion...
Integrative step-by-step approach to perform successful CTO interventions: from angiographic evaluation to strategy selection
20 May 2025 – From EuroPCR 2025
Master the integrative step-by-step approach to successful chronic total occlusion (CTO) interventions. This session emphasizes systematic angiographic evaluation and strategy selection ranging from simple to complex techniques, supplemented by blinded case discussions for practical learning.
Novelty in no-reflow management in STEMI patients
20 May 2025 – From EuroPCR 2025
Discover novel approaches to manage no-reflow phenomenon in STEMI patients. This session covers innovative therapies including the OPTI-STEMI trial strategies, mechanical thrombectomy, pharmacological interventions with Cangrelor, and super saturated oxygen therapy targeting coronary microcirculation preservation.
Align for the future with the Myval Octapro transcatheter heart valve series
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session offers a practical and evidence-based update on the Myval Octapro THV. Learn step-by-step techniques for valve-in-valve TAVI using the OctaAlign approach, and understand how intermediate sizes and precise deployment contribute to optimised hemodynamics and long-term durability.
Clinical insights are backed by key data...
Contemporary challenges in acute coronary syndromes
20 May 2025 – From EuroPCR 2025
Examine contemporary challenges in acute coronary syndromes (ACS) through recent trials and studies. Topics include long-term outcomes of deferred stenting, thrombectomy techniques, PCI in cardiogenic shock, and revascularisation strategies, providing a comprehensive update for clinical practice.
Broadening OPTIONs for LAA closure: innovations and outcomes
20 May 2025 – From EuroPCR 2025
Explore the latest insights into LAA closure from EuroPCR 2025. This session highlights results from the OPTION trial—the largest RCT comparing LAAC (with Watchman FLX) to DOAC therapy in AF patients undergoing ablation. The findings? Comparable stroke prevention at 3 years, with a 56 % reduction...
